Deutsche Bank’s ResMed RMD Stock Holding History

Deutsche Bank’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-9,268	Closed	-$3K	–	5646
2013 Q3	$3K	Buy	+9,268	New	+$450K	﹤0.01%	5274

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Deutsche Bank's RMD Position: Q2 2026 in Review

Deutsche Bank reduced its ResMed (RMD) stake by 7.1% in Q2 2026, selling an estimated $20.8M and leaving 1,322,313 shares worth $258M. The position accounts for 0.07% of the portfolio, ranked #233.

Deutsche Bank first reported a position in RMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $340M in Q4 2025. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Deutsche Bank held 1,322,313 shares of ResMed worth $258M as of Q2 2026.
Deutsche Bank sold 100,552 ResMed shares in Q2 2026, an estimated $20.8M.
ResMed made up 0.07% of Deutsche Bank's portfolio in Q2 2026, its #233 holding.
Deutsche Bank first reported a position in ResMed in Q2 2013 and has held it in 53 quarters since.
Deutsche Bank's ResMed position peaked at $340M in Q4 2025.
889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.